![Texas-Based Company Obtains OFAC License For Clinical Trials Of Diabetes Treatment Developed In Cuba — U.S. - Cuba Trade and Economic Council, Inc. Texas-Based Company Obtains OFAC License For Clinical Trials Of Diabetes Treatment Developed In Cuba — U.S. - Cuba Trade and Economic Council, Inc.](https://images.squarespace-cdn.com/content/v1/563a4585e4b00d0211e8dd7e/1521660440664-D5EYJ1N7J6QB0WGBMSMS/heberprot.jpg)
Texas-Based Company Obtains OFAC License For Clinical Trials Of Diabetes Treatment Developed In Cuba — U.S. - Cuba Trade and Economic Council, Inc.
![Introduction of the drug Heberprot-P expected to bring significant benefits to persons suffering from Diabetic foot Ulcers Introduction of the drug Heberprot-P expected to bring significant benefits to persons suffering from Diabetic foot Ulcers](http://health.gov.vc/health/images/stories/Top_news/heberprot-p.jpg)
Introduction of the drug Heberprot-P expected to bring significant benefits to persons suffering from Diabetic foot Ulcers
![Heberprot-P benefits in Cuba more than 43 thousand patients | Cuba Headlines – Cuba News, Breaking News, Articles and Daily Information Heberprot-P benefits in Cuba more than 43 thousand patients | Cuba Headlines – Cuba News, Breaking News, Articles and Daily Information](https://www.cubaheadlines.com/sites/default/files/imagecache/node_300x300/health-and-medicine/heberprot-1.jpg)
Heberprot-P benefits in Cuba more than 43 thousand patients | Cuba Headlines – Cuba News, Breaking News, Articles and Daily Information
![Heberprot-P arrives in the first world: Cuban drug registered in South Korea - Portal Provincial Avileño Heberprot-P arrives in the first world: Cuban drug registered in South Korea - Portal Provincial Avileño](https://www.ciegodeavila.gob.cu/images/actualidad/Acontecer/prot.jpg)